Neoplasm Treatment - India

  • India
  • In India, the Neoplasm Treatment market is expected to witness significant growth in the coming years.
  • By 2024, the projected revenue for this market is estimated to reach INR US$7.30bn.
  • Furthermore, it is anticipated that the market will continue to grow at an annual growth rate of 8.92% from 2024 to 2029, resulting in a market volume of INR US$11.19bn by 2029.
  • When compared to the global market, in the United States is expected to generate the highest revenue in the Neoplasm Treatment market, with an estimated revenue of US$90.56bn in 2024.
  • India's neoplasm treatment market is witnessing a surge in innovative therapies, driven by the country's robust pharmaceutical research and development capabilities.

Key regions: India, Japan, United States, United Kingdom, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)